ABVC Earnings — ABVC BioPharma, Inc. Common Stock Post-ER Performance | BigEarnings
ABVC — ABVC BioPharma, Inc. Common Stock
XNAS · Healthcare · Biotechnology
Price$1.39
Market Cap$36.1M
P/E—
52W Range$0.88 – $5.48
Next Earnings2026-08-12
About ABVC BioPharma, Inc. Common Stock
ABVC BioPharma Inc is a clinical stage biopharmaceutical company focused on development of new drugs and medical devices, all of which are derived from plants. It currently has six drugs and three medical devices in development. The firm specializes in botanically based solutions that deliver high efficacy with low toxicity for improved health outcomes. Its products include: Vitargus - ABV-1701, ABV-2001, ABV-2002, MDD ABV-1504, ADHD ABV-1505, ADHD ABV-1601, ABV-1501, ABV-1702, and ABV-1703.
🤖 AI Earnings Analysis
Early-stage biotech with **$1M operating loss** and minimal revenue visibility; shareholder meeting indicates ongoing governance focus amid capital-intensive R&D phase.
